Bridgefront Capital, LLC Integra Lifesciences Holdings Corp Transaction History
Bridgefront Capital, LLC
- $249 Million
- Q3 2024
A detailed history of Bridgefront Capital, LLC transactions in Integra Lifesciences Holdings Corp stock. As of the latest transaction made, Bridgefront Capital, LLC holds 11,645 shares of IART stock, worth $258,053. This represents 0.08% of its overall portfolio holdings.
Number of Shares
11,645Holding current value
$258,053% of portfolio
0.08%Shares
8 transactions
Others Institutions Holding IART
# of Institutions
241Shares Held
75.3MCall Options Held
585KPut Options Held
21.3K-
Black Rock Inc. New York, NY11.3MShares$249 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.74MShares$172 Million0.0% of portfolio
-
Morgan Stanley New York, NY5.26MShares$116 Million0.01% of portfolio
-
Eaton Vance Management Boston, MA4.22MShares$93.4 Million0.26% of portfolio
-
Fuller & Thaler Asset Management, Inc. San Mateo, CA3.97MShares$87.9 Million0.29% of portfolio
About INTEGRA LIFESCIENCES HOLDINGS CORP
- Ticker IART
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 83,518,200
- Market Cap $1.85B
- Description
- Integra LifeSciences Holdings Corporation develops, manufactures, and markets surgical implants and medical instruments for use in neurosurgery, extremity reconstruction, and general surgery. It operates in two segments, Codman Specialty Surgical and Tissue Technologies. The company offers neurosurgery and neuro critical care products, including...